Janux Therapeutics, Bristol Myers Squibb Enter Up to $850 Million Cancer Drug Deal
Janux Therapeutics has entered into a collaboration and licensing agreement with Bristol Myers Squibb (BMS) valued at up to USD […]
CANCER-DRUG-CANDIDATE
Janux Therapeutics has entered into a collaboration and licensing agreement with Bristol Myers Squibb (BMS) valued at up to USD […]
